FMR LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:16 am Sale | 2024-02-08 | 13G | KalVista Pharmaceuticals, Inc. KALV | FMR LLC | 50,970 0.147% | -1,260,032 (-96.11%) | Filing |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | KalVista Pharmaceuticals, Inc. KALV | FMR LLC | 1,311,002 5.325% | 299,502 (+29.61%) | Filing |
| 2021-06-10 11:37 am Sale | 2021-06-09 | 13G | KalVista Pharmaceuticals, Inc. KALV | FMR LLC | 1,011,500 4.141% | -628,778 (-38.33%) | Filing |
| 2021-02-08 10:25 am Sale | 2021-02-05 | 13G | KalVista Pharmaceuticals, Inc. KALV | FMR LLC | 1,640,278 9.142% | -150,513 (-8.40%) | Filing |
| 2020-04-10 2:01 pm Purchase | 2020-04-09 | 13G | KalVista Pharmaceuticals, Inc. KALV | FMR LLC | 1,790,791 10.034% | 123,813 (+7.43%) | Filing |
| 2020-02-07 11:24 am Purchase | 2020-02-06 | 13G | KalVista Pharmaceuticals, Inc. KALV | FMR LLC | 1,666,978 9.347% | 1,666,978 (New Position) | Filing |